Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional rV-GM-CSF in Metastatic Melanoma
NCT00002817Phase 2Unknown
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Apr 1996
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of vaccinia granulocyte-macrophage colony-stimulating factor recombinant virus in melanoma, sponsored by Sidney Kimmel Comprehensive Cancer Center. Status: unknown.
02
Drugs
vaccinia granulocyte-macrophage colony-stimulating factor recombinant virus
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00002817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002817.